Tabinda I. Riaz

Tabinda Riaz practices at Jersey Shore University Medical Center in Neptune, New Jersey, part of Hackensack Meridian Health.

Tabinda Riaz's NPI, 1316300759, was assigned on April 2, 2016. Tabinda Riaz holds New Jersey license 25MA10562100.

Tabinda Riaz's primary practice is Jersey Shore University Medical Center, at 1945 Rte 33, Neptune, NJ in Monmouth County. The practice phone is (732) 775-5500.

Tabinda Riaz's primary practice is Jersey Shore University Medical Center in Neptune, New Jersey, part of Hackensack Meridian Health. The medical group on file is Plover Inpatient Services LLC. Dmand AI also links Tabinda Riaz to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tabinda Riaz practices. Vendor and product names are available with a free account.

Internal medicine is Tabinda Riaz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Tabinda Riaz is licensed in New Jersey.

CMS data shows 952 Medicare services from Tabinda Riaz across 4 procedure codes in 2024, for 331 Medicare patients. Medicare paid $82,498 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 331 Medicare patients who saw Tabinda Riaz in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tabinda Riaz's median patient age at 66, with 57% women.

In 2024, Tabinda Riaz wrote 206 Medicare Part D claims for 79 patients. 90% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $577 in total drug cost. In 2023, CMS named 79 claims across 5 drugs.

Tabinda Riaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Tabinda Riaz, published from 2016 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Cellulose, Water Purification and Anti-Bacterial Agents. Tabinda Riaz has published most often in Carbohydr Polym.

CMS Open Payments shows 2 general payments to Tabinda Riaz from 2 drug and device companies from 2020 to 2021. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $15.